These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11654468)

  • 1. Proceedings of the Workshop on Inherited Breast Cancer in Jewish Women: Ethical, Legal, and Social Implications.
    Colen BD
    Law Med News; 1996; 2(1):1-4. PubMed ID: 11654468
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic screening for breast cancer susceptibility: a Torah perspective.
    Mosenkis A
    J Halacha Contemporary Society; 1997; No. 34():5-26. PubMed ID: 11660426
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic screening: survey of recent Halakhic periodical literature.
    Bleich JD
    Tradition; 2000; 34(1):63-87. PubMed ID: 11660816
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical issues related to BRCA gene testing in orthodox Jewish women.
    Mor P; Oberle K
    Nurs Ethics; 2008 Jul; 15(4):512-22. PubMed ID: 18515440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of counseling Ashkenazi Jewish women about breast cancer risk.
    Bowen DJ; Burke W; Culver JO; Press N; Crystal S
    Cultur Divers Ethnic Minor Psychol; 2006 Jan; 12(1):45-56. PubMed ID: 16594854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical issues in breast and ovarian cancer genetic counseling.
    Goelen G; Rigo A; Teugels E; Neyns B; Bonduelle M; De Grève J
    J Genet Couns; 1997 Dec; 6(4):497-8. PubMed ID: 11657665
    [No Abstract]   [Full Text] [Related]  

  • 10. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations in genetic counseling for inherited breast cancer predisposition.
    Robson ME; Offit K
    Semin Radiat Oncol; 2002 Oct; 12(4):362-70. PubMed ID: 12382194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
    Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
    Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a randomized study of telephone versus in-person breast cancer risk counseling.
    Helmes AW; Culver JO; Bowen DJ
    Patient Educ Couns; 2006 Dec; 64(1-3):96-103. PubMed ID: 16427245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic risk assessment for breast and ovarian cancer.
    O'Rourke Tiffen J; Pfeifer K; Fishman DA
    Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
    Spannuth WA; Thaker PH; Sood AK
    Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jewish theological and moral reflections on genetic screening: the case of BRCA1.
    Dorff EN
    Health Matrix Clevel; 1997; 7(1):65-96. PubMed ID: 10167179
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.
    Lester J
    Clin J Oncol Nurs; 2007 Oct; 11(5):619-22. PubMed ID: 17962169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer genetic risk assessment for individuals at risk of familial breast cancer.
    Guirguis-Blake J
    Am Fam Physician; 2008 Feb; 77(4):449-50. PubMed ID: 18326163
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
    Lewis MJ; Peterson SK
    Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.